Surprisingly, the PD-L1 levels in macrophages treated with EVs obtained from the plasma of NSCLC patients with OSA were higher than that with EVs obtained from the plasma of NSCLC patients without OSA. This evidence concerns the gene CD274 and non-small cell lung carcinoma.